Transforming modern cancer treatment in partnership with the world’s leading cancer center

The Focus Fund is an oncology-focused venture capital fund which invests in technologies and companies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven investment professionals.